Connect Biopharma Holdings Ltd. (CNTB)
2.07
+0.06
(+2.99%)
USD |
NASDAQ |
Sep 10, 16:00
2.07
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Shareholders Equity (Quarterly) : 26.86M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.86M |
| March 31, 2026 | 42.62M |
| December 31, 2025 | 41.98M |
| Date | Value |
|---|---|
| September 30, 2025 | 55.37M |
| June 30, 2025 | 71.34M |
| March 31, 2025 | 82.90M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.47M |
| Total Liabilities (Quarterly) | 16.61M |
| Debt to Equity Ratio | 0.0222 |
| Current Ratio | 2.369 |
| Net Debt Paydown Yield | 0.05% |